XML 59 R6.htm IDEA: XBRL DOCUMENT v3.23.3Close
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Cash flows from operating activities:    
Consolidated net income $ 713,157 $ 1,081,097
Adjustments to reconcile consolidated net income to net cash provided by (used for) operations:    
Depreciation and amortization 137,948 141,787
Amortization of stock-based compensation 34,868 35,009
Equity in earnings of affiliated companies (4,373) (4,726)
Deferred income taxes (53,038) 1,468
(Gain) loss on investments, net (4,649) 11,213
Other 4,078 2,673
Change in assets and liabilities:    
Accounts receivable, net 1,585,521 (628,974)
Inventories (525,020) (1,011,763)
Accounts payable (1,355,777) 166,602
Accrued expenses (88,348) 192,759
Other assets and liabilities (25,660) (128,909)
Net cash provided by (used for) operating activities 418,707 (141,764) Close
Cash flows from investing activities:    
Acquisition of property, plant, and equipment (57,775) (54,780)
Proceeds from collections of notes receivable 237 20,805
Proceeds from settlement of net investment hedge 10,725 0
Net cash used for investing activities (46,813) (33,975) Close
Cash flows from financing activities:    
Change in short-term and other borrowings 802,032 276,516
(Repayments of) proceeds from long-term bank borrowings, net (566,734) 1,238,268
Net proceeds from note offering 496,268 0
Redemption of notes (300,000) (350,000)
Proceeds from exercise of stock options 16,824 16,434
Repurchases of common stock (719,708) (725,254)
Settlement of forward-starting interest rate swap 56,711 0
Other (142) (137)
Net cash (used for) provided by financing activities (214,749) 455,827 Close
Effect of exchange rate changes on cash (766) (168,297) Close
Net increase in cash and cash equivalents 156,379 111,791 Close
Cash and cash equivalents at beginning of period 176,915 222,194
Cash and cash equivalents at end of period $ 333,294 $ 333,985